Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Reexamination Certificate
2006-12-15
2009-08-04
Richter, Johann R (Department: 1619)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
C514S252160, C514S401000, C514S818000
Reexamination Certificate
active
07569230
ABSTRACT:
The present invention provides compositions and stable liquid formulations comprising alpha adrenergic receptor antagonists and use thereof for increasing blood flow. In one embodiment, the stable liquid formulations of this invention are useful for reversing the effects of an anesthetic agent, preferably a long-lasting local anesthetic agent administered in conjunction with an alpha adrenergic receptor agonist.
REFERENCES:
patent: 4508715 (1985-04-01), Booth et al.
patent: 4659714 (1987-04-01), Watt-Smith
patent: 4888344 (1989-12-01), Sunagawa et al.
patent: 4938970 (1990-07-01), Hustead et al.
patent: 5149320 (1992-09-01), Dhaliwal et al.
patent: 5192527 (1993-03-01), Abrahmsohn
patent: 5261903 (1993-11-01), Dhaliwal et al.
patent: 5281591 (1994-01-01), Burke
patent: 6001845 (1999-12-01), Estok
patent: 6025396 (2000-02-01), Kim et al.
patent: 6043224 (2000-03-01), Lee et al.
patent: 6106866 (2000-08-01), Ranney
patent: 6291498 (2001-09-01), Horn
patent: 6432401 (2002-08-01), Weber et al.
patent: 6515006 (2003-02-01), Horn
patent: 6764678 (2004-07-01), Weber et al.
patent: 6872390 (2005-03-01), Weber et al.
patent: 2002/0082288 (2002-06-01), Horn
patent: 2004/0176408 (2004-09-01), Horn
patent: 2005/0080056 (2005-04-01), Horn
patent: 2005/0203099 (2005-09-01), Chen et al.
patent: WO 9505188 (1995-02-01), None
patent: WO 01/85171 (2001-11-01), None
U.S. Appl. No. 11/128,184, filed May 2005, Knowles, Julius.
Kaiser, Fran E, “Erectile Dysfunction” Merck Manuals Online Medical Library, http://www.merck.com/mmhe/sec21/ch240/ch240c.html#sec21-ch240-ch240b-175d, accessed Aug. 18, 2008.
Ahn, J. and Pogrel, M.A., “The effects of 2% lidocaine with 1:100,000 epinephrine on pulpal and gingival blood flow,”Oral Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 85:197-202, Mosby, Inc. (1998).
Alverez, D.J. and Rockwell, P.G., “Trigger Points: Diagnosis and Management,”Am. Fam. Physician 65:653-660, American Academy of Family Physicians (Feb. 2002).
Bernstein, R.M., and Rassman, W.R., “Limiting epinephrine in large hair transplant sessions,”Hair Transplant Forum International 10:39-42, New Hair Institute, Inc. (2000), accessed on Aug. 23, 2002 <http://www.800newhair.com/medical—publications/limiting—epinephrine.html>.
Crawford, R.A., et al., “The response of feline spinal pial arterioles to norepinephrine,”J. Neurosurg. 52:60-63, American Association of Neurological Surgeons (1990).
Edwall, B., et al., “Neuropeptide Y (NPY) and sympathetic control of blood flow in oral mucosa and dental pulp in the cat,”Acta Physiol. Scand. 125:253-264, Blackwell Scientific Publications (1985).
Hardy, S.J. and Agostini, D.E., “Accidental epinephrine auto-injector-induced digital ischemia reversed by phentolamine digital block,”J. Am. Osteopathic Assoc. 95:377-378, American Osteopathic Association (1995).
Heasman, P.A. and Jacobs, D.J., “A Clinical Investigation into the Incidence of Dry Socket,”Br. J. Oral Maxillofacial Surg. 22:115-122, Churchill Livingstone (1984).
Koss, M.C., “Differential neural activation of vascular α-adrenoceptors in oral tissues of cats,”Eur. J. Pharmacol. 440:53-59, Elsevier Science B.V. (Apr. 2002).
Maguire, W.M., et al., “Epinephrine-Induced Vasospasm Reversed by Phentolamine Digital Block,”Am. J. Emerg. Med. 8:46-47, W.B. Saunders (1990).
McGovern, S.J., “Treatment of accidental digital injection of adrenaline from an auto-injector device,”J. Accid. Emerg. Med. 14:379-380, BMJ Publishing Group (1997).
Medical Economics,Physicians' Desk Reference, Medical Economics Company, Inc., Montvale, NJ, pp. 3135-3137 (Nov. 2001).
Medical Economics,Physicians' Desk Reference, Medical Economics Company, Inc., Montvale, NJ, pp. 464, 2668, 2669 and 3268 (Nov. 2001).
Pimentel, L.A.S., and Goldenburg, R.C.D.S., “Local Injection of Hyaluronidase in Increasing Skin Flap Survival: An Experimental Study,”Revista da Sociedade Brasileira de Cirurgia Plastica 14:49-55, Sociedade Brasileira de Cirurgia Plastica (1999).
Robertson, V.J., et al., “Quantitative and Qualitative Analysis of the Pressor Effects of Levonordefrin,”J. Cardiovasc. Pharmacol. 6:929-935, Raven Press (1984).
Swinyard, E.A., “Local Anesthetics,” inRemington's Pharmaceutical Sciences, Osol, A. et al., eds., Mack Publishing Co., Easton, PA, pp. 991-1003 (1980).
Wilson, C.O., and Gisvold, O., eds.,Textbook of Organic Medicinal and Pharmaceutical Chemistry, 2ndEdition, J.B. Lippincott Company, Philadelphia, PA, pp. 25-27 (1954).
International Search Report for International Application No. PCT/US03/19440, mailed Dec. 10, 2003, International Searching Authority, U.S.A.
Office Action for U.S. Appl. No. 11/082,968, Chen, A.X., et al., filed on Mar. 18, 2005, mailed on Sep. 3, 2008.
Chen Andrew X
Knowles Julius
Weber Eckard
Lea Christopher R
Novalar Pharmaceuticals, Inc.
Richter Johann R
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Stabilized formulations of alpha adrenergic receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized formulations of alpha adrenergic receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized formulations of alpha adrenergic receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4057805